Telomir Pharmaceuticals, Inc. (TELO): Total Assets
$7.34M
As of 2025-12-31
$5.37M
As of 2026-06-30
n/m
3-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $7.34M | +454.5% | 2026-03-17, Balance as of period end |
| 2024-12-31 | $1.32M | -72.3% | 2026-03-17, Balance as of period end |
| 2023-12-31 | $4.77M | n/m | 2025-02-04, Balance as of period end |
| 2022-12-31 | $48.7K | n/a | 2024-03-29, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | 2025-12-31 | $7.34M | +454.5% |
| Ensysce Biosciences, Inc. (ENSC) | 2025-12-31 | $7.45M | +33.1% |
| Matinas BioPharma Holdings, Inc. (MTNB) | 2025-12-31 | $7.21M | -43.0% |
| Oncolytics Biotech Inc (ONCY) | 2025-12-31 | $7.58M | -43.5% |
| Rocket One Inc. (RKTO) | 2025-12-31 | $7.60M | -1.4% |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | $7.61M | +2.6% |
| Cannapharmarx, Inc. (CPMD) | 2025-12-31 | $7.02M | -35.2% |
| Acurx Pharmaceuticals, Inc. (ACXP) | 2025-12-31 | $7.69M | +99.3% |
| CV Sciences, Inc. (CVSI) | 2025-12-31 | $6.96M | -12.2% |
Compare TELO, ENSC, MTNB, ONCY side by side · Screen every company in Pharmaceutical Preparations ↗